Dabur Pharma Ltd.
Records under this name other than patents Dabur Pharma Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,838,569 | Process for preparation of paclitaxel trihydrate and docetaxel trihydrate Term ended Term ended Apr 22, 2023 · From the USPTO record | Term ended | Term ended Apr 22, 2023 | From the USPTO record |
| US 8,338,562 | Biocompatible, non-biodegradable, non-toxic polymer useful for nanoparticle pharmaceutical compositions Formerly held Lapsed on the fee record Ended Dec 25, 2020 · From the USPTO record | Lapsed on the fee record | Ended Dec 25, 2020 | From the USPTO record |
| US 6,322,817 | Formulations of paclitaxel, its derivatives or its analogs entrapped into nanoparticles of polymeric micelles, process for preparing same and the use thereof Formerly held Term ended Term ended Sep 23, 2019 · From the USPTO record | Term ended | Term ended Sep 23, 2019 | From the USPTO record |
| US 6,365,191 | Formulations of paclitaxel, its derivatives or its analogs entrapped into nanoparticles of polymeric micelles, process for preparing same and the use thereof Formerly held Term ended Term ended Sep 23, 2019 · From the USPTO record | Term ended | Term ended Sep 23, 2019 | From the USPTO record |
| US 7,235,647 | Intermediate and process for preparing of β- anomer enriched 21-deoxy,21,21-difluoro-D-ribofuranosyl nucleosides Formerly held Lapsed on the fee record Ended Jun 26, 2019 · From the USPTO record | Lapsed on the fee record | Ended Jun 26, 2019 | From the USPTO record |
| US 7,750,165 | Metaxalone polymorphs Formerly held Lapsed on the fee record Ended Jul 6, 2018 · From the USPTO record | Lapsed on the fee record | Ended Jul 6, 2018 | From the USPTO record |
| US 7,674,824 | Stable oxaliplatin formulation Formerly held Lapsed on the fee record Ended Mar 9, 2018 · From the USPTO record | Lapsed on the fee record | Ended Mar 9, 2018 | From the USPTO record |
| US 7,608,730 | Process for the preparation of an anti-tumor platinum (II)—complex Formerly held Lapsed on the fee record Ended Oct 27, 2017 · From the USPTO record | Lapsed on the fee record | Ended Oct 27, 2017 | From the USPTO record |
| US 6,900,342 | Anticancer taxanes such as paclitaxel, docetaxel and their structural analogs, and a method for the preparation thereof Lapsed on the fee record Ended May 31, 2017 · From the USPTO record | Lapsed on the fee record | Ended May 31, 2017 | From the USPTO record |
| US 6,670,345 | Betulinic acid derivatives for inhabiting cancer growth and process for the manufacture of betulinic acid Lapsed on the fee record Ended Dec 30, 2015 · From the USPTO record | Lapsed on the fee record | Ended Dec 30, 2015 | From the USPTO record |